相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Statin use and all-cause mortality in people living with HIV: a systematic review and meta-analysis
Olalekan A. Uthman et al.
BMC INFECTIOUS DISEASES (2018)
Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART-2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study
Takuya Oikawa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
Makoto Kinoshita et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study
Kanako Tsuji et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sex differences in post-traumatic stress disorder in cardiovascular patients after the Great East Japan Earthquake: a report from the CHART-2 Study
Takeo Onose et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2017)
The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD A Population-Based Cohort Study
Adam J. N. Raymakers et al.
CHEST (2017)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY
Paul S. Jellinger et al.
ENDOCRINE PRACTICE (2017)
Non-HDL Cholesterol and Triglycerides Implications for Coronary Atheroma Progression and Clinical Events
Rishi Puri et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
Michael G. Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Prognostic Impact of Statin Use in Patients With Heart Failure and Preserved Ejection Fraction - A Report From the CHART-2 Study -
Kotaro Nochioka et al.
CIRCULATION JOURNAL (2015)
Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease
Cheng-Gang Zhu et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
Christopher J. L. Murray et al.
LANCET (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: The Circulatory Risk in Communities Study (CIRCS)
Hiroyasu Iso et al.
ATHEROSCLEROSIS (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Amil M. Shah et al.
CIRCULATION-HEART FAILURE (2014)
Incidence, Predictors, and Subsequent Mortality Risk of Recurrent Myocardial Infarction in Patients Following Discharge for Acute Myocardial Infarction
Daisaku Nakatani et al.
CIRCULATION JOURNAL (2013)
Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations
Judith A. Finegold et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Incidence of Hospitalized Rhabdomyolysis with Statin and Fibrate Use in an Insured US Population
Kandace L. Amend et al.
ANNALS OF PHARMACOTHERAPY (2011)
Trend of Westernization of Etiology and Clinical Characteristics of Heart Failure Patients in Japan - First Report From the CHART-2 Study
Nobuyuki Shiba et al.
CIRCULATION JOURNAL (2011)
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction
Jens Jakob Thune et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy
Cheryl Enger et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients
Giuseppe Derosa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Fasting and Nonfasting Lipid Levels Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction
Anne Langsted et al.
CIRCULATION (2008)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia - The DIACOR (Diabetes and Combined Lipid Therapy Regimen) Study
Joseph B. Muhlestein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
T Pischon et al.
CIRCULATION (2005)
Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes
J Liu et al.
DIABETES CARE (2005)
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (The SAFARI Trial)
SM Grundy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Serum triglycerides and risk of coronary heart disease among Japanese men and women
H Iso et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
分享论文
